Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Core High Dividend ETF (HDV) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance

iShares Core High Dividend ETFTrade
Revolution Medicines Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares Core High Dividend ETF vs Revolution Medicines Inc. Common Stock — how do they compare? iShares Core High Dividend ETF trades at $28.74 (market cap $14.68B), while Revolution Medicines Inc. Common Stock trades at $191 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 2.7× iShares Core High Dividend ETF's market cap, and Revolution Medicines Inc. Common Stock is more actively traded (4,855,734 versus 2,925,562). Which is the better fit depends on your goals — on Pluang, investors hold iShares Core High Dividend ETF for 117 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.

HDVRVMD
Market Cap
$14.68B$40.32B
Volume
2,925,5624,855,734
52-Week High
$29.93$221.15
52-Week Low
$23.64$47.50
Typical Hold Time
117 Days0 Days
Sector
—Health
Enterprise Value
—$37.02B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Core High Dividend ETF

HDV (iShares Core High Dividend ETF) trades at $28.72, up 1.56% today with a bullish technical signal supported by moving averages. The ETF recently underwent a significant sector rebalancing, reducing healthcare exposure while increasing energy, staples, and utilities, resulting in heightened concentration risk with nearly 62% allocation to three sectors. Recent dividend payments of $0.06-$0.10 per share demonstrate consistent income generation despite the 3% yield not fully compensating for reduced diversification.

The outlook remains cautiously optimistic given the ETF's strong 2026 performance against the S&P 500, though investors face concentration risks from the recent sector shift. Key opportunities include the fund's competitive 0.08% expense ratio and dividend focus during market rotation, while risks center on sector concentration and whether the current yield adequately compensates for reduced diversification in the portfolio construction.

Revolution Medicines Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HDV
79% Buy21% Sell
Avg holding period · 117 Days
RVMD
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About iShares Core High Dividend ETF

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index is comprised of qualified income paying securities that are screened for superior company quality and financial health as determined by Morningstar, Inc.'s proprietary index methodology. The fund is non-diversified.

Read more on HDV →

About Revolution Medicines Inc. Common Stock

Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.

Read more on RVMD →